Skip to content
AtessiaAtessia Life Science Advisors
  • Home
  • Expertise
  • Services
    • Medicines
      • Exploitant – Pharmaceutical establishment
        • Find / Open a French “Exploitant” pharmaceutical company
        • Activities related to quality
        • External communications
        • Relation betwenn healthcare professionals & Compliance
        • Pharmacovigilance
      • Regulatory & Pharmaceutical Strategy
      • Research & Development Consulting
      • Marketing authorisation
        • Registration: Drafting & Submitting MA files
        • Post-MA lifecycle management
    • Medical devices
    • Consulting subscription
    • Audits
    • Regulatory monitoring
    • Training
    • Atessia Vigilances
  • Strengths
  • News
    • Company
    • Events
  • Blog
  • Join Atessia
  • Contact
  • English
    • Français
    • English

Blog

_Blog

What is the Requirement for Transparency of Conflicts of Interest with Healthcare Professionals in France?

Read more »
December 20, 2023
_Blog

What are the mechanisms for early and compassionate access in France?  

Read more »
November 28, 2023
_Blog

What about the classification of Marketing Authorization variations? 

Read more »
November 27, 2023
_Blog

What Are the French Rules for Influencers on Social Networks?

Read more »
October 20, 2023
_Blog

The Relationship Between the Healthcare Industry and Healthcare Professionals: Challenges and Developments

Read more »
June 22, 2023
_Blog

The Responsible Pharmacist status, a French specificity 

Read more »
April 20, 2023
_Blog

The serialisation system

Read more »
February 20, 2023
_Blog

The APQR review “à la française”

Read more »
February 1, 2023
_Blog

The consulting profession at ATESSIA

Read more »
January 24, 2023
_Blog

The mysterious thing that an Exploitant is

Read more »
July 7, 2022
_Blog

Registering gene therapy medicinal products

Read more »
June 23, 2022
_Blog

How to manage a non-GMP raw material in your MA files?

Read more »
June 20, 2022
Page1 Page2 Page3 Page4

ATESSIA, Life Science Advisors
3, Rue d’Uzès – 75002 PARIS
hello@atessia.fr
+33 1.70.22.66.19

Atessia Life Science Advisors

Follow-us

Legal notices

Terms and Conditions of Sale

ATESSIA SAS with capital of €5,000.00 I RCS PARIS 827 777 319

Copyright © 2021 | Powered by Atessia